Clinical trials on new cancer drugs still fall far short of including key data on several demographic groups
Despite widespread agreement that clinical trials should enroll a representative sampling of individuals from different age, gender, and racial and ethnic groups, a new Yale School of Medicine study shows that clinical trials ...